DTIL insider buying and SEC filings, explained
Precision Biosciences Inc. · CIK 1357874
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Company profile
- Exchanges
- Nasdaq
- Industry (SIC)
- Biological Products, (No Diagnostic Substances)
- State of incorporation
- DE
- Fiscal year end
- May 21
Insider activity in the last 12 months
Bought
$43K
Insiders who bought
2
Sold (not marked 10b5-1)
$0
Planned sales (10b5-1)
$466K
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Sep 28, 2026 | Purchase (code P) | Stanley Frankel (Director) bought 1,000 shares at $6.00 ($6K), reported as a purchase (code P). Holdings up 2% to 41,478 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Sep 30, 2026 |
| Sep 25, 2026 | Purchase (code P) | Melinda Brown (Director) bought 1,135 shares at $6.27 ($7K), reported as a purchase (code P). Holdings up 3% to 45,481 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Sep 29, 2026 |
| Sep 25, 2026 | Purchase (code P) | Geno J Germano (Director) bought 2,609 shares at $6.28 ($16K), reported as a purchase (code P). Holdings up 6% to 47,492 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Sep 29, 2026 |
| Feb 18, 2026 | Planned (10b5-1) | Michael Amoroso (CEO and Director) sold 20,559 shares at $3.84 ($79K), marked as a 10b5-1 plan trade. Holdings down 8% to 243,392 shares. | SEC filing Filed Feb 19, 2026 |
| Feb 18, 2026 | Planned (10b5-1) | John Alexander Kelly (CFO) sold 8,149 shares at $3.84 ($31K), marked as a 10b5-1 plan trade. Holdings down 6% to 125,883 shares. | SEC filing Filed Feb 19, 2026 |
| Feb 18, 2026 | Planned (10b5-1) | Dario Scimeca (General Counsel and Secretary) sold 4,925 shares at $3.84 ($19K), marked as a 10b5-1 plan trade. Holdings down 8% to 56,457 shares. | SEC filing Filed Feb 19, 2026 |
| Feb 18, 2026 | Planned (10b5-1) | J. Jefferson Smith (Chief Research Officer) sold 4,925 shares at $3.84 ($19K), marked as a 10b5-1 plan trade. Holdings down 4% to 121,926 shares. | SEC filing Filed Feb 19, 2026 |
| Jan 22, 2026 | Planned (10b5-1) | Michael Amoroso (CEO and Director) sold 34,799 shares at about $4.17 ($145K), marked as a 10b5-1 plan trade. Holdings down 15% to 196,154 shares. | SEC filing Filed Jan 22, 2026 |
| Jan 21, 2026 | Planned (10b5-1) | Dario Scimeca (General Counsel and Secretary) sold 8,854 shares at $4.03 ($36K), marked as a 10b5-1 plan trade. Holdings down 17% to 44,715 shares. | SEC filing Filed Jan 22, 2026 |
| Jan 21, 2026 | Planned (10b5-1) | John Alexander Kelly (CFO) sold 15,213 shares at $4.03 ($61K), marked as a 10b5-1 plan trade. Holdings down 13% to 106,448 shares. | SEC filing Filed Jan 22, 2026 |
| Jan 21, 2026 | Planned (10b5-1) | J. Jefferson Smith (Chief Research Officer) sold 10,200 shares at $4.03 ($41K), marked as a 10b5-1 plan trade. Holdings down 8% to 110,184 shares. | SEC filing Filed Jan 22, 2026 |
| Dec 16, 2025 | Purchase (code P) | Geno J Germano (Director) bought 3,000 shares at about $4.72 ($14K), reported as a purchase (code P). Holdings up 14% to 23,883 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Dec 17, 2025 |
| Dec 16, 2025 | Purchase (code P) | Stanley Frankel (Director) bought 2,700 shares at $4.70 ($13K), reported as a purchase (code P). Holdings up 16% to 19,478 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Dec 17, 2025 |
| Dec 15, 2025 | Purchase (code P) | Melinda Brown (Director) bought 1,381 shares at about $4.97 ($7K), reported as a purchase (code P). Holdings up 6% to 23,346 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Dec 17, 2025 |
| Nov 3, 2025 | Planned (10b5-1) | John Alexander Kelly (CFO) sold 1,303 shares at $6.49 ($8K), marked as a 10b5-1 plan trade. Holdings down 2% to 77,298 shares. | SEC filing Filed Nov 4, 2025 |
| Nov 3, 2025 | Planned (10b5-1) | Dario Scimeca (General Counsel and Secretary) sold 665 shares at $6.49 ($4K), marked as a 10b5-1 plan trade. Holdings down 2% to 28,258 shares. | SEC filing Filed Nov 4, 2025 |
| Nov 3, 2025 | Planned (10b5-1) | Michael Amoroso (CEO and Director) sold 3,409 shares at $6.49 ($22K), marked as a 10b5-1 plan trade. Holdings down 3% to 115,575 shares. | SEC filing Filed Nov 4, 2025 |
25 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
2 insiders bought in 30 days
$27K in purchases since Dec 16, 2025 · Purchases traded Dec 16, 2025 to Dec 16, 2025 · Closed
| Insider | Value | Traded | Source |
|---|---|---|---|
| Stanley Frankel (Director) | $13K | Dec 16, 2025 | SEC filing |
| Geno J Germano (Director) | $14K | Dec 16, 2025 | SEC filing |
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
| Filed | Items | Tag | Source |
|---|---|---|---|
| Nov 3, 2026, 8:10 AM ET 8-K | Earnings released (Item 2.02) | SEC filing |
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow DTIL in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.